Eli Lilly not yet ready to unfreeze UK investments, says pharma boss
US drugmaker wants changes to types of drugs approved in Britain
US drugmaker wants changes to types of drugs approved in Britain

US pharmaceutical group ‘optimistic’ about reaching deal with British government

Dave Ricks says Britain will miss out on medicines and future investment unless it pays more

Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs

Life sciences should be a natural place to look for growth

Shares have soared more than 40% this year over strong demand for weight-loss and diabetes drugs

Global pharmaceutical companies are aggressively searching for new medicines in China